RenovoRx CEO Records Insider Buy of 24,300 Shares, Acquisition Valued at $0
RenovoRx Chief Executive Officer Shaun Bagai, through The Bagai Family Trust, acquired 24,300 shares of RenovoRx common stock on March 20, 2026, in a transaction reported with a total value of $0. The trust also received 12,150 warrants that are immediately exercisable at $1.9326 and carry an expiration tied to March 30, 2029, or an operational sal…